Abiomed, Inc.
Abiomed, Inc. Closes Sale of Common Stock in Public Offering
Published in Health Business Week, April 13th, 2007
Abiomed, Inc. (NASDAQ: ABMD) announced the completion of the public offering of 5,000,000 shares of its common stock at $13.75 per share. The net proceeds to Abiomed from the offering are approximately $63.6 million, after deducting underwriting discounts and commissions and estimated offering expenses. The underwriters have been granted a 30-day option to purchase up to an additional 750,000 shares of Abiomed's common stock to cover over-allotments, if any.
The offering was managed by Morgan Stanley & Co. Incorporated and UBS Securities LLC as joint book-running managers.
Keywords: Abiomed, Inc., Abiomed Inc., Biotechnology Business, Biotechnology...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2007-04-13)
More Articles from Health Business Week
- AARP
AARP Teams With Iowa Business, Industry, Education and Labor to Spur Action on Health Care, Long-Term Financial Security - Abbott
Abbott Named to DiversityInc's 'Top 50 Companies for Diversity' List - Abiomed, Inc.
Abiomed Expands Availability of Impella Circulatory Support Technologies with Regulatory Approvals in India - Achillion Pharmaceuticals, Inc.
Achillion Reports 2006 Fourth Quarter and Year-End Financial Results - Acne Vulgaris
CollaGenex Pharmaceuticals Initiates 40 mg Cohort in the Phase II Dose-Finding Study of Incyclinide for the Treatment of Acne - Advanced Medical Institute Inc.
Advanced Medical Institute Inc. Shares Cleared for Trading on the OTCBB - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
